Skip to content

Effects of Baduanjin Combined Balance Training on Gait and Posture Control of Patients with Mild and Moderate Parkinson's Disease

Effects of Baduanjin Combined Balance Training on Gait and Posture Control of Patients with Mild and Moderate Parkinson's Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-17011875
Enrollment
Unknown
Registered
2017-07-05
Start date
2017-08-01
Completion date
Unknown
Last updated
2017-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's Disease

Interventions

Balance function training group:Balance function training group
Control group:Conventional drug therapy
Baduanjin group:Baduanjin aerobic exercise

Sponsors

Affiliated Lianyungang Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. a clear diagnosis of primary Parkinson's disease, Meet the 2013 Criteria of Guidelines for the diagnosis of Parkinson 's disease of European Neurological Union: 1) reduced capasity of movement; 2) meets at least one of the following clinical manifestations, including muscle rigidity; resting tremor; posture instability. 3) at least meet the following criteria: unilateral disease; resting tremor; disease progressively progress; after the onset of persistent asymmetric involvement; levodopa treatment at first effective; 2. Hoehn-Yahr grade 1-3, able to walk independently; 3. 1 week before the election to the beginning of the trial did not adjust the drug, medication during treatment unchanged; 4. auditory, visual and cognitive ability is normal.

Exclusion criteria

Exclusion criteria: (1) various secondary Parkinson's syndrome (including traumatic, drug-induced, tumor, vascular, toxic, hydrocephalus, etc.) and Parkinson's syndrome; (2) previous bone and joint disease or cerebrovascular disease, and the impact of walking or balance function; (3) heart failure, severe hypertension and other serious medical diseases; (4) do not cooperate with the inspection and training.

Design outcomes

Primary

MeasureTime frame
The bulk sensory mean index (A.T.E);Gait test results;

Secondary

MeasureTime frame
Unified Parkinson’S Disease Rating Scale,UPDRS;Serum Tyrosine hydroxylase,TH;Serum HVA;Serum alpha-synuclein;

Countries

China

Contacts

Public ContactZenglin Cai

Affiliated Lianyungang Hospital of Xuzhou Medical University

caizengling@163.com+86 18961322001

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 13, 2026